Literature DB >> 6134106

Inhaled antibiotics in cystic fibrosis.

M A Wall, A B Terry, J Eisenberg, M McNamara, R Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134106     DOI: 10.1016/s0140-6736(83)92428-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  Is prolonged rotavirus infection a common cause of protracted diarrhoea?

Authors:  M Sood; I W Booth
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Evidence for using nebulised antibiotics in cystic fibrosis.

Authors:  S P Conway
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

3.  Inhaled micronised gentamicin powder: a new delivery system.

Authors:  J M Goldman; S M Bayston; S O'Connor; R E Meigh
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

4.  Microparticles for inhalational delivery of antipseudomonal antibiotics.

Authors:  Michael D Tsifansky; Yoon Yeo; Oleg V Evgenov; Evangelia Bellas; John Benjamin; Daniel S Kohane
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

5.  Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Authors:  Greg L Plosker
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

Review 6.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

Review 7.  Aerosol antibiotic treatment in cystic fibrosis.

Authors:  J M Littlewood; S W Smye; H Cunliffe
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

8.  Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation.

Authors:  E Ring; E Eber; W Erwa; M S Zach
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

9.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

Review 10.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.